Paladin Partners’s Teladoc Health TDOC Stock Holding History

Paladin Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119	Hold	14	–	–	﹤0.01%	210
2026 Q1	$76	Hold	14	–	–	﹤0.01%	209
2025 Q4	$98	Buy	+14	New	+$110	﹤0.01%	213

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Paladin Partners's TDOC Position: Q2 2026 in Review

Paladin Partners held its Teladoc Health (TDOC) position steady in Q2 2026 at 14 shares worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Paladin Partners first reported a position in TDOC in Q4 2025 and has held it in 3 quarters since. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Paladin Partners held 14 shares of Teladoc Health worth $119 as of Q2 2026.
Paladin Partners left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Paladin Partners's portfolio in Q2 2026, its #210 holding.
Paladin Partners first reported a position in Teladoc Health in Q4 2025 and has held it in 3 quarters since.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Paladin Partners's 13F filing for Q2 2026, filed 7 Aug 2026.